Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("ONOZAWA Y")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 33

  • Page / 2
Export

Selection :

  • and

PLATELET AGGREGATION IN MYELOPROLIFERATIVE DISORDERS = AGREGATION PLAQUETTAIRE DANS LES SYNDROMES MYELOPROLIFERATIFSNOMURA T; ONOZAWA Y.1974; THROMBOSIS DIATHESIS HAEMORRHAG., SUPPL.; ALLEM.; DA. 1974; NO 60; PP. 247-256; BIBL. 14 REF.; (PLATELETS THROMB. INHIBITORS. PROC. SEMIN.; HONOLULU, HAWAII; 1973)Conference Paper

EMPERIPOLESIS AND ANNULATE LAMELLAE IN ERYTHROLEUKAEMIA = EMPERIPOLESE ET "LAMELLES ANNULAIRES" DANS L'ERYTHROLEUCEMIEKAMIYAMA R; ONOZAWA Y; YAMAGUCHI H et al.1983; SCANDINAVIAN JOURNAL OF HAEMATOLOGY; ISSN 0036-553X; DNK; DA. 1983; VOL. 30; NO 4; PP. 331-336; ABS. ENG; BIBL. 17 REF.; FIGArticle

THE USE OF HEPARIN IN THE THERAPY OF ACUTE PROMYELOCYTIC LEUKEMIA WITH DAUNORUBICIN = UTILISATION DE L'HEPARINE DANS LE TRAITEMENT DE LA LEUCEMIE AIGUE A PROMYELOCYTES AVEC LA DAUNORUBICINENOMURA T; KOMIYA M; KASHIWAGI H et al.1974; THROMBOSIS DIATHESIS HAEMORRHAG., SUPPL.; ALLEM.; DA. 1974; NO 60; PP. 271-279; BIBL. 16 REF.; (PLATELETS THROMB. INHIBITORS. PROC. SEMIN.; HONOLULU, HAWAII; 1973)Conference Paper

ACTIVATION OF PLATELETS IN CANCER, ESPECIALLY WITH REFERENCE TO GENESIS OF DISSEMINATED INTRAVASCULAR COAGULATIONYAHARA Y; OKAWA S; ONOZAWA Y et al.1983; THROMBOSIS RESEARCH; ISSN 0049-3848; USA; DA. 1983; VOL. 29; NO 1; PP. 27-35; BIBL. 24 REF.Article

Breakpoints in Philadelphia chromosome (Ph1)-positive leukemiasHIROSAWA, S; AOKI, N; SHIBUYA, M et al.Japanese journal of cancer research. 1987, Vol 78, Num 6, pp 590-595, issn 0910-5050Article

Acute nonlymphocytic leukemia following lung cancer in a patient with a constitutional supernumerary chromosomeMINAMIHISAMATSU, M; GREGORIO, J. S; ONOZAWA, Y et al.Cancer genetics and cytogenetics. 1988, Vol 35, Num 2, pp 263-268, issn 0165-4608Article

1200V FS-IGBT module with enhanced dynamic clamping capabilityOTSUKI, M; ONOZAWA, Y; YOSHIWATARI, S et al.International Symposium on Power Semiconductor Devices & ICs. 2004, pp 339-342, isbn 4-88686-060-5, 4 p.Conference Paper

Hypercalcaemia due to all-trans retinoic acidAKIYAMA, H; NAKAMURA, N; NAGASAKA, S et al.Lancet (British edition). 1992, Vol 339, Num 8788, pp 308-309, issn 0140-6736Article

Microangiopathy without hemolysis in a patient following allogeneic bone marrow transplantationAKIYAMA, H; YOSHINAGA, H; ENDOU, M et al.Bone marrow transplantation (Basingstoke). 1997, Vol 20, Num 3, pp 261-263, issn 0268-3369Article

Recombinant human erythropoietin (rhEPO) administration to marrow donorsAKIYAMA, H; TANIKAWA, S; TAKAMOTO, S et al.International journal of hematology. 1995, Vol 62, Num 3, pp 145-149, issn 0925-5710Article

Systemic infection due to atypical mycobacteria in patients with chronic myelogenous leukemiaAKIYAMA, H; MARUYAMA, T; UETAKE, T et al.Reviews of infectious diseases. 1991, Vol 13, Num 5, pp 815-818, issn 0162-0886Article

Granulocytic sarcoma of the ovary in patients with acute myelogenous leukemiaYAMAMOTO, K; AKIYAMA, H; MARUYAMA, T et al.American journal of hematology. 1991, Vol 38, Num 3, pp 223-225, issn 0361-8609Article

Phase I study of TAS-102 treatment in Japanese patients with advanced solid tumoursDOI, T; OHTSU, A; YOSHINO, T et al.British journal of cancer. 2012, Vol 107, Num 3, pp 429-434, issn 0007-0920, 6 p.Article

Effect of hydrogen-radical annealing for SiO2 passivationNAGAYOSHI, H; ONOZAWA, Y; IKEDA, M et al.Japanese journal of applied physics. 1996, Vol 35, Num 8B, pp L1047-L1049, issn 0021-4922, 2Article

Etoposide with/without G-CSF with busulfan and cyclophosphamide as conditioning for bone marrow transplantationKANDA, Y; AKIYAMA, H; TANIKAWA, S et al.American journal of hematology. 1996, Vol 51, Num 4, pp 265-268, issn 0361-8609Article

Transfusion-associated graft-versus-host disease in a presumably immunocompetent patient after transfusion of stored packed red cellsSUZUKI, K; AKIYAMA, H; TAKAMOTO, S et al.Transfusion (Philadelphia, PA). 1992, Vol 32, Num 4, pp 358-360, issn 0041-1132Article

Effects of interleukin-12 on natural killer cell cytotoxicity and the production of interferon-γ and tumour necrosis factor-α in patients with myelodysplastic syndromesOGATA, K; TAMURA, H; YOKOSE, N et al.British journal of haematology. 1995, Vol 90, Num 1, pp 15-21, issn 0007-1048Article

Utility and safety of Hickman catheters for venous access after bone marrow transplantationKEMAGAI, T; SAKAMAKI, H; TANIKAWA, S et al.Internal medicine (Tokyo. 1992). 1998, Vol 37, Num 3, pp 286-291, issn 0918-2918Article

Mortality and medical morbidity beyond 2 years after allogeneic hematopoietic stem cell transplantation: experience at a single institutionMUNAKATA, W; SAWADA, T; KOBAYASHI, T et al.International journal of hematology. 2011, Vol 93, Num 4, pp 517-522, issn 0925-5710, 6 p.Article

Plasma soluble interleukin-2 receptor level in patients with primary myelodysplastic syndromes : a relationship with disease subtype and clinical outcomeOGATA, K; YOKOSE, N; AN, E et al.British journal of haematology. 1996, Vol 93, Num 1, pp 45-52, issn 0007-1048Article

Dose-escalation study of CHOP with or without prophylactic G-CSF in aggressive non-Hodgkin's lymphomaITOH, K; OHTSU, T; WAKITA, H et al.Annals of oncology. 2000, Vol 11, Num 10, pp 1241-1247, issn 0923-7534Article

Invasive infection due to Trichosporon cutaneum in patients with hematologic malignanciesKATAOKA-NISHIMURA, S; AKIYAMA, H; SAKU, K et al.Cancer. 1998, Vol 82, Num 3, pp 484-487, issn 0008-543XArticle

Assessment of therapeutic potential of interleukin 2 for myelodysplastic syndromesOGATA, K; YOKOSE, N; ITO, T et al.British journal of haematology. 1994, Vol 86, Num 3, pp 562-567, issn 0007-1048Article

Effects of purified human native granulocyte colony-stimulating factor (G-CSF) on proliferation of blast progenitors in acute myeloblastic leukemiaNARA, N; MUROHASHI, I; SUZUKI, T et al.American journal of hematology. 1988, Vol 27, Num 2, pp 84-88, issn 0361-8609Article

Normalized natural killer (NK) cell activity in long-term remission of acute leukaemia = Activité normalisée des cellules NK dans une rémission à long terme de la leucémie aiguëYODA, Y; ABE, T; TASHIRO, A et al.British journal of haematology. 1983, Vol 55, Num 2, pp 305-309, issn 0007-1048Article

  • Page / 2